SCHEMBL6965440

SCHEMBL6965440

N#CC1(NC(=O)[CH]CC2CCCCC2)CCN(CC2CCCCC2)C1

nearest known ligand 0.54

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CTSS P25774 18/20 0.54
CTSL P07711 3/20 0.37
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5375313 0.87 CTSS (0.43) CTSSCTSL
SCHEMBL5367971 0.85 CTSS (0.42) CTSSCTSL
SCHEMBL5364168 0.85 CTSS (0.48) CTSSCTSLOPRM1OPRL1
SCHEMBL5357225 0.85 CTSS (0.48) CTSSCTSLOPRM1OPRL1
SCHEMBL5362011 0.84 CTSS (0.49) CTSSCTSL
SCHEMBL5357983 0.84 CTSS (0.47) CTSSCTSLOPRM1
SCHEMBL5362069 0.84 CTSS (0.41) CTSSCTSL
SCHEMBL5361127 0.83 CTSS (0.48) CTSSCTSL
SCHEMBL6972941 0.83 CTSS (0.59) CTSSOPRM1SMN1; SMN2
SCHEMBL5356435 0.82 CTSS (0.46) CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-B1 NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMA (US) 2003-07-02 EP disclosed